| Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer’s disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET | European journal of nuclear medicine and molecular imaging |  | | 2025 | 25 | 223 |
|
| Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment | European journal of nuclear medicine and molecular imaging | | | 2025 | 26 | 789 |
|
| Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline | Brain | | | 2024 | 17 | 251 |
|
| A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | | | 2024 | 97 | 123 |
|
| The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline | Alzheimer's & dementia | | | 2024 | 140 | 264 |
|
| Automatic Classification of Conclusions from Multi-Tracer Reports of PET Brain Imaging in Cognitive Impairment | Studies in health technology and informatics | | | 2024 | 159 | 158 |
|
| Prognostic value of imaging-based ATN profiles in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | | | 2023 | 106 | 173 |
|
| ATN profile classification across two independent prospective cohorts | Frontiers in medicine | | | 2023 | 145 | 209 |
|
| Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways | European journal of nuclear medicine and molecular imaging | | | 2023 | 125 | 122 |
|
| Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting | The Journal of nuclear medicine | | | 2023 | 189 | 332 |
|
